Pacira | PCRX - Ebit


Pacira reported $13.15M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Astellas Pharma JPY 134.54B 30.13B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Coherus Biosciences USD -45.43M 3.19M Mar/2025
Heron Therapeutics USD -4.46M 5.76M Sep/2024
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
J&J USD 5.11B 2.3B Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025
Xoma USD -10.08M 4.4M Jun/2024
Zoetis USD 835M 140M Dec/2025